News GSK plc

Equities

GSK

GB00BN7SWP63

Market Closed - London S.E. Other stock markets 11:35:15 2024-06-07 am EDT			5-day change	1st Jan Change
1,629 ^GBX	-0.67%		-7.78%	+12.33%

12:02am	US FDA expands GSK's RSV vaccine approval to adults aged 50 to 59	RE
Jun. 07	GSK says FDA Approves Expanded Age Indication For Arexvy, RSV Vaccine For Adults Aged 50-59 At Increased Risk	RE

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

US FDA Approves Expanded Age Indication for GSK’s AREXVY, the First Respiratory Syncytial Virus (RSV) Vaccine for Adults Aged 50-59 at Increased Risk	06:58pm	BU
US FDA expands GSK's RSV vaccine approval to adults aged 50 to 59	06:02pm	RE
GSK : DO NOT COURIER US FDA approves expanded age indication for GSK’s Arexvy, the first respiratory syncytial virus (RSV) vaccine for adults aged 50-59 at increased risk	Jun. 07	PU
GSK says FDA Approves Expanded Age Indication For Arexvy, RSV Vaccine For Adults Aged 50-59 At Increased Risk	Jun. 07	RE
GSK -CLINICAL DEVELOPMENT PROGRAMME CONTINUES TO EVALUATE SAFETY…	Jun. 07	RE
GSK - FDA APPROVES EXPANDED AGE INDICATION FOR GSK'S AREXVY, FIR…	Jun. 07	RE
GSK Vaccine to Prevent Respiratory-Tract Disease Approved for Expanded Use	Jun. 07	DJ
GSK : JP Morgan maintains a Sell rating	Jun. 07	ZD
GSK accelerates oligonucleotide platform and pipeline medicines with acquisition of Elsie Biotechnologies \| GSK	Jun. 07	AQ
GSK Closes Up to $50 Million Purchase of US-based Elsie Biotechnologies	Jun. 06	MT
GSK: acquisition of US biotech Elsie	Jun. 06	CF
GSK Buys Elsie Biotechnologies for Up to $50 Million	Jun. 06	DJ
GSK Buys Elsie Biotechnologies for $50 Million	Jun. 06	MT
GSK : accelerates oligonucleotide platform and pipeline medicines with acquisition of Elsie Biotechnologies	Jun. 06	PU
GSK plc acquired Elsie Biotechnologies for $50 million.	Jun. 05	CI
HSBC Lifts GSK PT, Maintains Reduce Rating	Jun. 05	MT
Berenberg raises Taylor Wimpey to 'buy'	Jun. 05	AN
GSK : DZ Bank remains Neutral	Jun. 04	ZD
Just when you think you've got it all figured out...	Jun. 04
GSK PLC : Frightened markets create an entry opportunity in GSK	Jun. 04